Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenjun Zhang

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
The discovery of diazepinone-based 5-HT3 receptor partial agonistsDavid D Manning, Cheng Guo, Zhenjun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndromeDavid D Manning, Christopher L Cioffi, Alexander Usyatinsky, et al.
Bioorganic & Medicinal Chemistry|May 3, 2026
Design, synthesis and biological evaluation of 2,4,5-trisubstituted 7H-Pyrrolo[2,3-d]pyrimidine derivatives as potent EGFR tyrosine kinase inhibitors against the C797S acquired resistance mutationHao Zhang, Tianlong Lan, Rui Li, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Bioorganic & Medicinal Chemistry Letters|April 24, 2014
The discovery of diazepinone-based 5-HT3 receptor partial agonistsDavid D Manning, Cheng Guo, Zhenjun Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndromeDavid D Manning, Christopher L Cioffi, Alexander Usyatinsky, et al.
Bioorganic & Medicinal Chemistry|May 3, 2026
Design, synthesis and biological evaluation of 2,4,5-trisubstituted 7H-Pyrrolo[2,3-d]pyrimidine derivatives as potent EGFR tyrosine kinase inhibitors against the C797S acquired resistance mutationHao Zhang, Tianlong Lan, Rui Li, et al.
Pageof 6